Cargando…
Hydroxychloroquine enhances the antitumor effects of BC001 in gastric cancer
Gastric cancer is an important cancer type worldwide, the anti-angiogenic agent BC001 can target the vascular endothelial growth factor receptor 2 (VEGFR2), and significantly suppresses the growth of gastric cancer BGC823 cells in vitro and in vivo. However, numerous results indicated that antiangio...
Autores principales: | Wang, Wei, Liu, Linqing, Zhou, Yucheng, Ye, Qiang, Yang, Xiuli, Jiang, Jinying, Ye, Ziqi, Gao, Feng, Tan, Xiaolu, Zhang, Guobing, Fang, Qingxia, Xuan, Zixue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615922/ https://www.ncbi.nlm.nih.gov/pubmed/31268153 http://dx.doi.org/10.3892/ijo.2019.4824 |
Ejemplares similares
-
Associations of DDX60L With the Clinical Features and Prognosis of Hepatocellular Carcinoma
por: Ye, Ziqi, et al.
Publicado: (2022) -
Integrative genomic analysis of N6-methyladenosine-single nucleotide polymorphisms (m(6)A-SNPs) associated with breast cancer
por: Xuan, Zixue, et al.
Publicado: (2021) -
[Corrigendum] Fully human VEGFR2 monoclonal antibody BC001 attenuates tumor angiogenesis and inhibits tumor growth
por: Xuan, Zi-Xue, et al.
Publicado: (2023) -
Fat mass and obesity-associated protein promotes the tumorigenesis and development of liver cancer
por: Ye, Ziqi, et al.
Publicado: (2020) -
Subcutaneous bortezomib might be standard of care for patients with multiple myeloma: a systematic review and meta-analysis
por: Ye, Ziqi, et al.
Publicado: (2019)